Published in Vaccine Weekly, April 11th, 2007
DVC has served as prime systems contractor for the JVAP since 1997, and has since made considerable progress in the advanced development of several biodefense vaccines. Since 2005, DVC has initiated Phase 1 clinical trials for three JVAP biodefense vaccine development programs, all of which were developed by the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID). These are a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly